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Background: Colorectal adenocarcinomas are characterized by abnormal mitochondrial DNA (mtDNA) copy number
and genomic instability, but a molecular interaction between mitochondrial and nuclear genome remains unknown.
Here we report the discovery of increased copies of nuclear mtDNA (NUMT) in colorectal adenocarcinomas, which
supports link between mtDNA and genomic instability in the nucleus. We name this phenomenon of nuclear
occurrence of mitochondrial component as numtogenesis. We provide a description of NUMT abundance and
distribution in tumor versus matched blood-derived normal genomes.
Methods: Whole-genome sequence data were obtained for colon adenocarcinoma and rectum adenocarcinoma
patients participating in The Cancer Genome Atlas, via the Cancer Genomics Hub, using the GeneTorrent file
acquisition tool. Data were analyzed to determine NUMT proportion and distribution on a genome-wide scale.
A NUMT suppressor gene was identified by comparing numtogenesis in other organisms.
Results: Our study reveals that colorectal adenocarcinoma genomes, on average, contains up to 4.2-fold more
somatic NUMTs than matched normal genomes. Women colorectal tumors contained more NUMT than men.
NUMT abundance in tumor predicted parallel abundance in blood. NUMT abundance positively correlated with
GC content and gene density. Increased numtogenesis was observed with higher mortality. We identified YME1L1,
a human homolog of yeast YME1 (yeast mitochondrial DNA escape 1) to be frequently mutated in colorectal
tumors. YME1L1 was also mutated in tumors derived from other tissues. We show that inactivation of YME1L1
results in increased transfer of mtDNA in the nuclear genome.
Conclusions: Our study demonstrates increased somatic transfer of mtDNA in colorectal tumors. Our study also
reveals sex-based differences in frequency of NUMT occurrence and that NUMT in blood reflects NUMT in tumors,
suggesting NUMT may be used as a biomarker for tumorigenesis. We identify YME1L1 as the first NUMT suppressor
gene in human and demonstrate that inactivation of YME1L1 induces migration of mtDNA to the nuclear genome.
Our study reveals that numtogenesis plays an important role in the development of cancer.
Keywords: Cancer, Tumor, Colorectal cancer, Mitochondria, Mitochondrial DNA, YME1L1, NUMT, Numtogenesis,
mtDNA transfer, Genetic instability* Correspondence: htiwari@uab.edu; kksingh@uab.edu
†Equal contributors
1Department of Biostatistics, School of Public Health, University of Alabama
at Birmingham, Birmingham, Alabama 35294, USA
3Departments of Genetics, Environmental Health, Center for Free Radical
Biology, Center for Aging and UAB Comprehensive Cancer Center, University
of Alabama at Birmingham, Birmingham, Alabama 35294, USA
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Srinivasainagendra et al. Genome Medicine  (2017) 9:31 Page 2 of 15Background
Natural transfer of mitochondrial DNA (mtDNA) into the
nuclear genomes of eukaryotic cells is a well-established
and evolutionarily ongoing process. The nuclear copies of
mtDNA are described as NUMTs (nuclear mtDNA se-
quences) [1]. Frequently, intact mitochondria containing
mtDNA, mitochondrial RNA (mtRNA), and mitochon-
drial proteins are also reported to localize into the nucleus
[2–9]. We have named this phenomenon of occurrence of
nuclear mitochondria as numtogenesis. We define numto-
genesis as the occurrence of any mitochondrial compo-
nents into the nucleus or nuclear genome. Numtogenesis
is reported in at least 85 sequenced eukaryotic genomes
[1]. These include human, plant, yeast, fruit fly, Plasmo-
dium, Caenorhabditis, and other species [1, 10, 11]. In
human, NUMT insertions are estimated to occur at a rate
of ~5 × 10−6 per germ cell per generation [12].
Evolutionary studies suggest that the origin and inser-
tion of germline NUMTs are distributed non-randomly
in humans and other mammals [13–15]. Germline
NUMTs tend not to originate from the mtDNA dis-
placement loop (“d-loop”), and they tend to be located
in damage-prone regions of the nuclear genome, such as
open chromatin and fragile sites [13–15]. These studies
implicate NUMTs in double-strand break repair [13]. The
mechanism(s) of NUMT accumulation is not well under-
stood. It is suggested that mitochondria migrate towards
the nucleus and accumulate near the nuclear membrane
[16–18]. The most parsimonious mechanism explaining
NUMT accumulation involves de novo transposition from
the mitochondrion to the nucleus; however, NUMTs are
also known to accumulate via segmental duplication
(sometimes within repetitive elements), and possibly RNA
retro-transposition [19–21]. The human genome contains
between 755 and 1105 germline NUMTs, with mtDNA
identities ranging from 64–100% [12, 22]. Germline
NUMTs with the lowest similarity to mtDNA have been
evolutionarily conserved for tens of millions of years,
while the most recent insertions occurred after certain
Homo sapiens populations migrated to Eurasia [22–26].
Human germline NUMTs are relatively well described but
little is known about the somatic NUMT and its role in
human pathology [27].
We and others have demonstrated that mito-nuclear
interactions play a key role in tumorigenesis [28–35],
but a role of mtDNA integration within the nuclear
genome remains relatively unexplored. In this study, we
analyzed the prevalence of NUMT in colorectal cancer
(CRC) because a number of mitochondrial associations
are relatively well characterized in CRC. There is a re-
ported relationship between CRC risk and mtDNA copy
number [36–38], and there are associations between
germline mtDNA variants and CRC risk and mortality
[39, 40]. Similarly, colorectal adenocarcinomas tend tohave aberrant mtDNA copy number and somatic variant
frequencies compared to matched blood-derived normal
genomes [41–44]. We differentiated two classes of
NUMTs with distinct characteristics, those that are inher-
ited in the germline and those that are somatic NUMTs
acquired during tumorigenesis. We present the first quan-
titative analysis on the abundance of somatic NUMTs in
human colorectal adenocarcinoma genomes relative to
matched blood-derived normal samples. Further, we com-
pare the distributions of somatic NUMTs and germline
NUMTs, describe sex-based differences in numtogenesis,
and demonstrate that NUMT abundance in blood reflects
NUMT abundance in tumor. In addition, we identify
YME1L1 as the first “NUMT suppressor” gene in humans
whose inactivation leads to increased numtogenesis.
Methods
Data harvesting
Whole-genome sequence data were obtained for colon
adenocarcinoma (COAD) and rectum adenocarcinoma
(READ) patients participating in The Cancer Genome
Atlas (TCGA), via the Cancer Genomics Hub (CGHub)
[45], using the GeneTorrent file acquisition tool. In
order to appraise alternative protocols for transactions
on big-data endpoints, we evaluated GTFuse, an
innovate software that offers faster access to DNA se-
quence data without the need for staging the data lo-
cally. Although data bandwidth hungry, GTFuse still
enabled us to rapidly prototype our research on selected
regions of the genome, thereby indicating signals of
NUMT deposition in the nuclear genome. A symbiotic
combination of GeneTorrent and GTFuse was used to
choreograph the downstream data analysis pipeline. Our
data harvester robots adopt a high-throughput analysis
model by spreading GTFuse across a computational clus-
ter fabric available locally on-campus At the time of
manuscript generation, although the GTFuse web-link
within AnnaiSystems webportal was unavailable, an
alternate web URL https://annaisystems.zendesk.com/hc/
en-us was found through web search means.
Quality control
TCGA sequence data for individuals with matched colo-
rectal tumor and blood-derived normal samples were
harvested from CGHub. Downloaded data went through
an intense quality control (QC) pipeline, which involved
the use of (a) clinical information downloaded from
TCGA Data Matrix, (b) short-reads alignment statistics
derived from the Binary AlignMent (BAM) sequence
data downloaded from CGHub, and (c) tagging and
elimination of duplicate reads in the alignment data
(BAM) using a popular next-generation sequencing tool,
Picard 2.5. All sequence data used in this study were
generated at Harvard Medical School using Illumina
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were mapped to the hg18 human reference assembly.
Since paired-end read technology offers better mapping
coverage, improved directional sequence accuracy, and
reliable mapping of reads to a reference genome, we
used sequencing datasets generated using Illumina’s
paired-end read technology as opposed to single-end
read technology. Paired-end reading, with its increased
coverage across several genomic bases, also improves
the ability to identify relative positions of the two ends
of a single read, especially when each read-end maps to
different genomes, nuclear and mitochondrial.
Further, a second-level QC was conducted based on
the clinical annotations of the samples (Fig. 1). Partici-
pants were excluded a priori if even one of the following
conditions as unmet (a) one or more elements of TCGA
barcode differed between matched tumor and blood-
derived healthy samples (i.e., sample, vial, analyte, and
plate identifiers), (b) multiple alignment data (BAM files)
per aliquot were reported when using CGHub’s sequence
data query tool, cgquery, and (c) self-reported race and
ethnicity status was not white or black. After theFig. 1 Quality control (QC) pipeline. Upstream QC pipeline conducted
on aligned sequence data processed at Harvard Medical School
(HMS-HK) was downloaded from TCGA CGHub. Clinical annotations
for the matched tumor and blood-derived normal samples were
downloaded from TCGA data matrix. COAD colon adenocarcinoma,
READ rectum adenocarcinoma, HMS-HK Harvard Medical Schoolcomplete QC process, the final dataset included 57 colo-
rectal tumor and 57 matched blood-derived normal gen-
ome alignment files (BAM files). Figure 1 illustrates the
complete QC pipeline.
Data analytics
A two-pronged analytic approach is taken to determine
(a) NUMT proportion and distribution on a genome-wide
scale and (b) hot spots in the nuclear and mitochondrial
genomes experiencing more than blood-derived healthy
(normal) NUMTabundance.
The primary obstacle to quantifying non-homologous
recombinant elements from high-throughput sequence
data is the reliable detection of reads that map to the se-
quence breakpoint. Although conceptually intuitive, the
mapping and alignment of breakpoint reads is compli-
cated by the large number of NUMT inserts that are not
represented in the reference genome sequence. Alterna-
tively, de novo genome assembly is computationally in-
tensive, and any low-stringency mapping algorithm that
would accurately identify insertion sites would also re-
turn many false positive hits. Fortunately, paired-end
read technology offers a convenient and reliable method
of detecting genome structural rearrangements, effectively
bypassing an intensive search for non-homologous break-
points. In the mapping step, paired-end coordinates are
recorded for each read, which we filtered using simple text
edit scripts. We used utilities of the SAMtools framework
to quantify all paired-end reads that mapped to different
chromosomes (mismatches). Further NUMTs were fil-
tered from the mismatch output files, where one paired
end mapped to mtDNA and the other to a nuclear coordi-
nate. Since breakpoints were not precisely identified, we
used the paired-end coordinate as a proxy for nuclear in-
sertion site because the average distance between properly
mapped reads was short (ca. 150 bp).
In addition to challenges presented by NUMT detection,
we recognized challenges related to data normalization
that are not addressed by traditional copy-number ana-
lyses. NUMTs represent a subset of the mapped genomic
read count, and local representation cannot be assumed
constant across tumor genomes. To study the NUMT
abundance, we defined a metric for calculating relative
NUMT abundance from high-throughput genomic se-
quence data. First, relative NUMT abundance was nor-
malized to mapped read count across a given genomic
region, expressed as a ratio (Pij):
Pij ¼ NijMij
Let Nij and Mij represent NUMT read count and
mapped read count within a genomic interval (i), re-
spectively, for genome type (j) for an individual; where a
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chromosome (chr), chromosome arm (arm), or 2.5-mbp
sliding window (win); and where genome type (j) is either
tumor (t) or matched blood-derived healthy (h) genome of
an individual. The change in tumor and matched healthy
NUMT proportions is defined as ΔPi = Pit − Pih and the ra-
tio is given as:
Ri ¼ Pit  Pihð Þ−1
where Ri represents the proportional fold-change in
NUMT abundance within a genomic region (i) for tumor
(t) versus matched blood-derived healthy (h) genomes.
When sub-genomic regions (e.g., sliding windows and
cytobands) were compared, Pih was replaced with Pih ,
where Pih is the average NUMT proportion within the
genomic interval for all blood-derived healthy samples
sharing the same plate barcode to avoid zero denomin-
ator because blood-derived healthy samples may not
have any NUMTs within the short regions.
The Ri derived earlier can be less than or greater than
1 due to the asymmetric property of ratios (e.g., where
Ri = 0.5 represents a change in the opposite direction,
i.e., there are twice as many NUMTs in healthy samples
compared to tumor; and similarly, Ri = 2.0 represents a
change in the positive direction, i.e., there are twice as
many NUMTs in tumor samples compared to their
matched blood-derived normal samples). In order to
compare NUMTs between tumor and blood-derived
healthy samples within the genomic regions, it is neces-
sary to rescale Ri values less than one and to collapse
values of one and negative one to zero. Further, we de-
fined an indicator value Si to denote the direction of





R=i ¼ RSii  Si
Let the Ri
/represent the rescaled proportional fold-
change in relative NUMT abundance between tumor
and matched blood-derived normal samples. Ri
/was cal-
culated for the nuclear genome using five nested data
partitions, where i represents whole genomes (gen),
chromosomes (chr), chromosome arms (arm), cytobands
(cyt), and sliding windows (win). For nuclear genome-
scale comparisons, normalization to mapped reads (Mij)
did not include sex chromosomes due to sequence repre-
sentation bias associated with differences in chromosome
length. For small-partition comparisons (e.g., sub-band),
samples were pooled before normalization to avoid bias
associated with zero denominators. For the mitochondrialgenome, Ri
/was calculated for three nested data partitions,
where i represents genome (mtg), replication strand (mst),
and gene (mgn).
The relationship between Rarm
/ and mapped read count
was evaluated with linear regression to assess whether
NUMT transposition is coincident with aneuploidy.
The relationships between Rwin
/ were evaluated between
GC content to assess whether transcriptional activity
predisposes the nuclear genome to integration of
non-homologous DNA. All statistical analyses were
conducted in the R statistical environment (http://
www.R-project.org/). The NUMT proportions and abun-
dance in blood-derived normal and primary tumor sites
are quantified in Additional file 1: Table S1.YME1L1 gene knockout and NUMT analyses in isolated
nuclear DNA
Using the CRISPR-Cas9 method, we knocked out the
human YME1L1 gene in human breast epithelial MCF-7
cells as described earlier [46]. To avoid any mtDNA con-
tamination in NUMT analyses, we isolated nuclear frac-
tions free of mitochondrial contamination. Briefly,
YME1L1 knockout and wild-type MCF-7 cells were lysed
using lysis buffer (10 mM HEPES, pH 7.9, 10 mM KCl,
0.1 mM EDTA) containing 10% IGEPAL detergent for
10 min at room temperature and centrifugation at
15,000xg for 3 minutes was carried out to pellet the in-
tact nuclei. To completely avoid cytoplasmic fraction
contamination in the nuclear pellet, the lysis step was re-
peated one more time. The purity of the nuclear fraction
was ascertained by performing western blotting for
mitochondrial encoded cytchrome oxidase II (COXII)
protein. Nuclear DNA was prepared from the nuclear
pellet using the NAOH boiling method [47]. Mitochon-
drial DNA content in the nuclear fraction was analyzed
by real-time PCR by absolute quantification using
primers for COXII (mtDNA-encoded gene) and Beta-2
microglobulin (B2M; nuclear DNA-encoded gene). B2M
served as an internal control.Yeast transformation and genetic selection
Yeast expression vectors (pYX113, pPT31-yYme1, and
pYX113-hYme1L) were transformed using the lithium
acetate, single-stranded DNA, polyethylene glycol
method [48–50]. Following transformation, yeast harbor-
ing the desired vector was selected using synthetic drop-
out (SD) medium (0.67% [w/v] nitrogen base without
amino acids, 0.07% [v/v] drop-out amino acid mix
(-His/-Trp/-Ura), 0.02% [w/v] L-histidine and excluding
the amino acid that is a selectable marker, 2% [w/v] dex-
trose, and 1.5% agar for agar plates). Single cell colonies
from plates lacking uracil were cultured in glucose
medium and 1 × 104 and 5 × 107 or 5 × 108 cells were
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tryptophan.
The yeast strains throughout this study were grown in
YPD medium (1% [w/v] yeast extract, 2% [w/v] bacto-
peptone, 2% [w/v] dextrose) or YPG medium (1% [w/v]
yeast extract, 2% [w/v] bacto-peptone, 3% [w/v] glycerol,
pH 4.9) at 30 °C. The yeast strains constructed and used
in this study are detailed in Table 1. The yeast Yme1-1
strain (PTY62) was transformed with a plasmid expressing
the yeast YME1 (yYme1) or human YME1L1 (hYme1L1)
gene under the alcohol dehydrogenase (ADH) promoter.
Results
Adenocarcinoma genomes contain increased NUMTs
compared to healthy genomes
Since mitochondrial abnormalities are frequently de-
scribed in cancer, we asked whether mitochondrial dys-
function results in increased prevalence of NUMTs in
tumors. Constitutively, tumor genomes contained more
NUMTs than matched blood-derived healthy genomes
when normalized to mapped read pairs. When scanned
for NUMT proportion and distribution on a genome-
wide scale across 57 samples, tumor genomes contained,
on average, 4.42-fold more NUMTs than healthy normal
genomes. Box plots (Fig. 2a, b) indicate the mean, dis-
persion, and skewness of NUMT density for the genome
groups. Although both tumor and matched normal ge-
nomes show right-skewed distributions (Fig. 2c), the third
quartile (3.43 × 10−6) of the normal blood genome group
is less than the first quartile (3.13E-6) of the tumor
genomes, indicating significant difference in the NUMT
density. A one-tailed, paired t-test was performed on
tumor and matched blood-derived healthy samples to
determine the statistical significance (P value 8.79 × 10−13)
of the log transformed NUMT abundance levels. In one
case, however, 22-fold more tumor NUMTs were observed
in a Caucasian woman. This individual’s vital status was
pronounced as deceased after reporting her pathologic
tumor stage as I. These studies suggest that colorectal
adenocarcinomas contain increased NUMTs compared to
blood-derived healthy NUMTs.
NUMT abundance in blood correlates with NUMT
abundance in tumor
Increasingly, molecular characteristics of tumors are
demonstrated to be reflected in the blood of cancerTable 1 Sacharomyces cerevisiae strains used in the study
Strain Genotype Mitochondrial genotype




PTY62-hYme1L1patients. We therefore envision that increased NUMT
incidence observed in tumors may be found in the
matched blood of cancer patients. In order to determine
the predictability of tumor NUMT density based on the
NUMT frequency in matched blood-derived healthy
samples, a simple linear regression was performed on
the log base 2-transformed proportions of NUMTs in
blood-derived healthy genomes (Pgenh) and tumor ge-
nomes (Pgent). Linear regression revealed a positive rela-
tionship between Pgent and Pgenh with an R2 = 0.17, P
value = 0.0016 (Fig. 3a, b). These results indicate that there
is a positive correlation between proportions of NUMTs
in blood-derived and primary tumor in colorectal cancer
samples.
Colorectal tumors in women harbor more NUMTs
Recent studies suggest hormonal regulation of mitochon-
drial functions [51]. Therefore, we delineated NUMT dis-
tribution among males and females. Colorectal tumors of
women harbored more NUMTs than those of men (Fig. 4).
Women had a median NUMT fold change proportion of
4.52 compared 3.1 for men. We conclude that tumors
from women contained more NUMTs than those from
men.
NUMT abundance is associated with patient survival
It is conceivable that increased NUMT insertions may
confer metastatic disease resulting in the death of pa-
tients. Therefore, we determined NUMT abundance and
correlated it with patient survival. Figure 5 demonstrates
that the NUMT abundance is amplified many fold in de-
ceased individuals. Based on the survival rate among
both sexes and vital status, there appears to be corrobor-
ating evidence that NUMTs in colorectal tumor ge-
nomes of women have a tendency to be amplified and
are associated with patient survival. However, further
analyses with larger sample sizes are required to make a
definite conclusion. When overlaying these findings with
circos integrators (Fig. 6; Additional file 2: Figures S1;
Additional file 3: Figure S2), three of the four deceased
individuals were reported to have pathologic tumor stage
IIIC and IVA. Overall, except for one individual (women,
stage I, deceased status), these results suggest that
NUMT abundance increases with tumor grade and is
significantly amplified in women.
NUMT abundance positively correlates with GC content
and gene density
GC content is positively correlated with gene density;
hence, regions of high GC content have higher relative
gene density compared to regions of low GC content
[52]. Also, as Giemsa-negative chromosomal bands are
gene-rich regions of DNA compared to bands positive
for Giemsa staining [53], we extended our NUMTanalyses
Fig. 2 Distribution of NUMT proportions in tumor and normal genomes. a Distribution of NUMT proportions in 57 samples with matched tumor
and blood-derived normal genomes. NUMT proportion is defined as the ratio between NUMT read count and total mapped read count on a
genome-wide scale. The mean and standard deviation, respectively, across the 57 samples are 8.31 × 10−6 and 7.11 × 10−6 for tumor genomes
and 2.65 × 10−6 and 2.49 × 10−6 for normal genomes. A two-tailed paired t-test conducted between the NUMT proportions for 57 (COAD + READ)
samples revealed a P value of 1.63 × 10−5. When comparing the NUMT proportions between the cancer site group versus blood-derived group
using a two-tailed unequal variance t-test, a P value of 1.43 × 10−5 was observed for COAD samples (N = 36) and 3.82 × 10−3 for READ samples
(N = 21). b Fold change in the tumor NUMT proportions compared to blood-derived normal genomes across colon (COAD) and rectum (READ)
cancer samples. Tumor genomes contained 4.42-fold more NUMTs than blood-derived normal genomes. A two-tailed unequal variance t-test
conducted between the NUMT abundance of colon cancer samples (N = 36) and rectal cancer samples (N = 21) revealed a P value of 0.91, indicating
no difference in the NUMT abundance between the two cancer sites, colon and rectum. c Right-skewed distribution, log transformed, and one-tailed
paired t-test performed on tumor and matched blood-derived normal samples to determine the statistical significance (P value 8.79 × 10−13) of the
log-transformed NUMT abundance levels
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positive relationship between NUMT abundance and GC
content of gene-rich regions, having an abundance fold-
change of 4.2 or more (Fig. 7).
Overall, among the groups that had a fold change of 2
or more in NUMT abundance, although the low GC-
content cytobands gpos50 and gpos100 were at the top
of the NUMT abundance list for chromosomal cytoband
windows, GC-rich “gneg” regions were prominent
among cytobands exhibiting more than a 4.2-fold change
in NUMT abundance. This pattern observed for the out-
lier data above 4.2 fold-change of NUMT abundance
within GC-rich regions of gneg clearly shows a strong
correlation between elevated NUMT abundance and GC
content. Based on Fig. 7, as indicated by data points
above the third quartile level, gneg regions are account-
able for the greater than normal NUMT abundance, in-
dicating a positive correlation between gene density and
NUMT abundance. A previous study has shown that
gpos100 sub-bands are also enriched with LINEs [54],and other researchers have demonstrated secondary
amplification via LINE transposition to be an important
mechanism of NUMT accumulation [11, 20]. Our results
corroborate the empirical evidence. Clearly, a great deal
of new research is needed to elucidate the causes and
consequences of NUMT transposition. We hope that
our discovery will serve as an impetus for such inquiry.Mitochondrial fragile sites associated with NUMTs
To identify fragile sites in the mitochondrial genomes
that act as hotspots for mtDNA to immigrate into the
nuclear genome, paired-end reads with one end mapping
to the mitochondrial genome and the other end to the
nuclear genome, NUMTs were further investigated. As
illustrated in Fig. 8, fragile sites were identified within
complex I (ND1) and complex IV (MT-CO1/COX1,
COX III) mitochondrial regions, which are known for
harboring mutations in different cancer sites. Based on
the migration pattern of NUMTs, breakpoint sites in
Fig. 3 Log2-transformed NUMT proportions in tumor and blood-derived normal (Pij) genomes. a Log2-transformed NUMT proportions in tumor
and normal genomes showcasing the difference in their means, indicating higher NUMT distribution in tumor genomes compared to matched
blood-derived normal genomes. A two-tailed paired t-test conducted between the log2-transformed NUMT proportions for 57 samples revealed
a P value of 1.87 × 10−11, showing significant difference in the log-transformed NUMT proportions between primary tumors and blood-derived
normal genomes. b Relationship between abundance measures of blood-derived normal genome NUMTs and tumor genome NUMTs showing a
positive relationship with R2 = 0.17 and P value = 0.0016
Fig. 4 NUMT abundance across disease–sex combination. Colorectal tumors from women have higher NUMT abundance proportion (tumor NUMT/
blood normal NUMT) than those from men. Women had a median NUMT fold change abundance of 4.52 (range 0.11 to 22.9) compared 3.1 for men
(range 0.53 to 8.3). COAD colon adenocarcinoma, READ rectum adenocarcinoma. To investigate the sex difference in the NUMT abundances, an
unequal variance t-test was performed on the raw NUMT proportions observed by the members of the two sex groups stratified by “blood-normal”
and “primary tumor” classifications. The P value was 0.03 between males (N = 23) and females (N = 34) for blood-derived normal samples and 0.08 for
tumor samples
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Fig. 5 NUMT abundance distribution according to vital status.
a Increased NUMT abundance in deceased individuals with colorectal
tumors. Although a Mann–Whitney U test showed a P value of 0.04
between the NUMT abundances of the Alive and Deceased groups, the
very small sample size (N= 4) of the deceased group warrants further
investigation with datasets enriched for deceased vital status. b NUMT
proportions categorized based on disease (colon and rectal) and sex
combination. This vital status observation in combination with NUMT
abundance among sex-specific samples appears to be an early indicator
of death events among colorectal cancer women with higher
proportions of NUMTs
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nuclear genome of colorectal cancer.
YME1L1 inactivation leads to increased numtogenesis
In the yeast Saccharomyces cerevisiae, YME1 is reported
to be an important suppressor of mtDNA migration to
the nucleus [55]. Interestingly, the YME1L1 gene en-
codes the human homologue of yeast mitochondrial
AAA (ATPases associated with diverse cellular activities)
metalloprotease, Yme1p. YME1L is a functional homologue
of Yme1p, with conserved roles in mitochondrial assembly,
integrity, and DNA metabolism [56]; however, its function
in suppressing NUMTs is not known.
We conducted in silico YME1L1 mutation analysis in
all colorectal cancer cases (n = 57) used for NUMT ana-
lysis in this study. We determined that of 57 CRC tu-
mors, ~16% contained mutations in YME1L1. A total of
24 mutations (five exonic, 17 intronic, and two in the 3′UTR) in YME1L1 were identified. All five exonic muta-
tions were frameshift mutations (Fig. 9a, b).
We expanded our analysis of Yme1L1 in TCGA data-
base. This analysis revealed a high incidence of Yme1L1
mutations in CRC (Fig. 9c). The mutations in Yme1L1
include missense and synonymous substitutions and
inframe and frameshift deletions (Fig. 9c). Most of the
mutations in Yme1L1 in human colorectal cancer fall
into two categories: missense substitutions (~68%) and
synonymous substitutions (20%). The relative distribu-
tion of various mutations is summarized as a pie chart
in Fig. 9c. We also analyzed Yme1L1 mutations in other
human cancer types and observed a high mutation fre-
quency in all the tested cancer types (Fig. 9d).
We determined whether inactivation of the human
YME1L1 gene increases NUMT formation. For this, we
created a YME1L1 knockout in a human cell line using
YME1L1 gene-specific CRISPRs. We prepared nuclear
fractions free of mitochondrial contamination and quan-
tified the amount of mtDNA present in the nuclear frac-
tion of these cells. We observed a strikingly increased
amount of mtDNA in the nuclear fraction of YME1L1
knockout cells compared to wild-type cells (Fig. 9e).
These results identify YME1L1 as the first NUMT sup-
pressor gene in humans and suggest that inactivation of
YME1L1 leads to increased numtogenesis.Human homologue of YME1 suppresses migration of
mtDNA to the nucleus
We asked whether the phylogenetically conserved role
of human YME1L1 can rescue the migration of mtDNA
in a yeast strain in which YME1 is disrupted. We utilized
the Yme1-1 yeast strain, which harbors a mutation which
leads to inactivation of the YME1 gene [57]. In this strain,
the auxtotrophic endogenous nuclear TRP1 gene is de-
leted and inserted into the mitochondrial genome. Since
the required transcription machinery for TRP1 is only
present in the nucleus, the mitochondrially inserted TRP1
gene is only functional when it migrates to the nucleus,
permitting analysis of mtDNA migration to the nucleus
[57, 58].
To determine whether human Yme1L1 is expressed in
the Yme1-1 strain, western blotting was performed. In-
deed, hYme1L1 was expressed in the Yme1-1 hYme1L1
strain (Fig. 9f ). When the Yme1-1 vector was plated
under tryptophan selection, it showed a significantly
large number of colonies (Fig. 9g). These data support a
previous observation that migration of mtDNA to the
nucleus is high in Yme1-1 cells [57]. Yme1-1 cells ex-
pressing yeast Yme1 (yYme1) display only a few (<50)
tryptophan-positive colonies, suggesting that accumula-
tion of mtDNA fragments in the nucleus in the Yme1-1
strain was prevented to a greater degree by re-introducing
Fig. 6 NUMT density in tumor and normal genomes (sorted by disease (T2), sex (T1), and age at initial pathologic diagnosis (T3)). Each peripheral
node represents a TCGA sample whose blood-derived normal and tumor genomes were used in this study. From the outside to inside, tracks are
ordered from 1 to 7 (T1–T7). T1: Sample sex where red nodes represent female and blue nodes represent male. T2: Disease type information. Rectal
adenocarcinoma (READ) is rendered as green bands and colon adenocarcinoma (COAD) as red bands. T3: Age at initial pathologic diagnosis ranging from
30 to 90 years. White and black filled bars represent white and black race, respectively. T4: Red columns represent NUMT proportion in tumor genomes and
green columns represent blood-derived normal NUMT proportion. T5: Vital status of the patients where red indicates deceased individuals and green alive
status. T6: Stage of tumor represented in grey-scale—stage I white, stage II grey, stage III dark grey, and stage IV black. T7: Fold-change in NUMT abundance.
Samples at <1-fold are rendered as colored bands; 1–4-fold, blue; 4–8-fold, green; 8–12-fold, yellow; 12–20-fold, orange; and >20-fold, red
Fig. 7 Correlation of NUMT abundance and GC content. Positive correlation between gene density and NUMT abundance. GC content is
positively correlated with gene density; hence, regions of high GC content have higher relative gene density than regions of low GC content.
Sample sizes (number of chromosome bands annotated by a certain Giemsa stain value) for the various Giemsa stain groups are as follows; gneg,
N = 366; gpos100, N = 75; gpos25, N = 73; gpos50, N = 109; and gpos75, N = 82
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Fig. 8 Top fragment sites of the mitochondrial genome identified in the nuclear genome. Genes on the mitochondrial genome and their
potential fragile sites involved in the process of numtogenesis. Bands from the outside to inside represent: mitochondrial gene names; gene
segments; numtogenesis regions of blood-derived normal samples (green bands); numtogenesis regions of primary tumor samples (red bands);
numtogenesis regions unique to tumor samples but not observed in blood-derived normal samples (blue bands)
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boring hYme1L1 also produced significantly low number
of tryptophan-positive colonies compared to Yme1-1 cells
(Fig. 9g). However, the number of typtophan-positive col-
onies in this case was a little higher (>100) compared to
yYme1-expressing cells. This suggests that hYme1L1 can
partially rescue the phenotype of mtDNA escape in Yme1-
1. We conclude that hYme1L1 suppresses migration of
mtDNA to the nucleus.
Discussion
Numtogenesis, a natural phenomenon leading to migra-
tion of mitochondria, mitochondrial proteins, mtRNA,
or mtDNA into the nucleus, is an ongoing cellular
process reported in eukaryotic cells [2–9]. Although the
occurrence of NUMT and the phenomenon of numto-
genesis have been reported, its role in cellular and or-
ganismal function and in human health and disease
remains relatively unexplored. Our study revealed that
somatic NUMTs are frequently found in colorectal cancer.
Consistent with our finding, two previous studies have as-
sociated NUMTs with carcinogenesis; one that found
NUMTs containing LINEs in rat and mouse tumors [20]
and a study of a cervical carcinoma cell line [19].We provide evidence for increased NUMT insertions
in the nuclear genomes of colorectal adenocarcinomas
relative to matched control samples. NUMT occurrence
was influenced by pathological cancer stage and sex
between tumor and control groups. Germ line NUMT
insertions leading to diseases have been identified [59].
These diseases include severe plasma factor VII defi-
ciency and bleeding diathesis [60], mucolipodosis IV
[61], Usher syndrome [62], and a rare Pallister-Hall syn-
drome [63]. These NUMT insertions were found in cod-
ing genes. NUMT insertions in these genes can reduce
cellular fitness, leading to cellular dysfunction-induced
cell death, which may underlie these human diseases
[64]. Conceivably, somatic NUMT insertion in tumor
suppressor gene(s) may disrupt pathways which can con-
tribute to tumorigenesis. Similarly, NUMT may activate on-
cogene(s) involved in tumor development. Indeed,
integration of mtDNA fragments in theMYC locus in HeLa
cells [65] and in the nuclear genome of mouse embryonic
fibroblasts [66] has been identified. It appears that the inte-
gration of mtDNA in the nuclear genome of mouse embry-
onic fibroblasts led to the malignant transformation [66].
Increased somatic NUMT insertion in the nuclear
genome of tumors may be associated with mitochondrial
Fig. 9 Human YME1L1 inactivation leads to increased numtogenesis. TCGA tumor sample data used in this study were screened for mutations in
the YME1L1 gene. A total of 24 mutations (five exonic, 17 intronic, and two in the 3′ UTR) in YME1L1 were identified. All five exonic mutations
were frameshift mutations. a, b The position of these mutations in the YME1L1 gene (a) and protein (b). c The total colorectal cancer samples
available in TCGA database were analyzed on 4 April 2016 for mutations in Yme1L1 and their types determined. d Mutations in Yme1L1 in other
cancers were also analyzed using the cBioPortal database. Altered frequency of Yme1L1 mutations in different cancer types are represented. e mtDNA
content in nuclear fractions, i.e., NUMT accumulation was analyzed in wild-type (WT) and YME1L1 knockout (Yme1L1-KO) human cell lines. NUMT
accumulation was about fourfold increased in YME1L1-KO cells compared with wild-type cells. Data are expressed as mean ± standard error of the
mean (sem); *P < 0.05, Student’s t-test. f, g The yeast PTY33-Yme1-1 (ρ+, TRP1) strain was transformed with empty plasmid and plasmids expressing
yYme1 and hYme1L1 with URA marker as indicated. Transformed cell colonies were selected by synthetic dropout medium lacking URA. f Whole cell
lysate from the Yme1-1 vector, Yme1-1 yYme1, and Yme1-1 hYme1L1 strains was subjected to SDS-PAGE and western blotting was performed with
antibodies against hYme1L1 and β-actin. g Yme1-1 vector, Yme1-1 yYme1, and Yme1-1 hYme1L1 cells were spread on plates lacking tryptophan; the
experiment was performed three times in triplicate. Data are expressed as mean ± sem; *P < 0.05, Student’s t-test
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feature of a variety of tumors and is described to be a
hallmark of cancer [67–72]. We have previously demon-
strated that mitochondrial dysfunction induces genomic
instability in the nucleus [30, 31, 33]. However, genetic
instability associated with mitochondrial dysfunction has
been described to be point mutations or chromosomal
aneuploidy [73–75]. The nuclear genome instability was
induced due to increased oxidative stress caused by the
changes in the nucleotide pool [30]. Hadler et al. [76]
proposed “a unitary hypothesis for carcinogenesis”,
speculating that a breakdown of mito-nuclear symbiosis
leads to development of cancer; they suggested release
of mtDNA due to damage to the mitochondrial mem-
branes. Using a sliding window approach, we determined
NUMT insertion in tumor genomes. When we searched
for the origin of these nuclear NUMT landing sites
among colorectal cancer samples, we found threepotential fragile sites within the mitochondrial genes
ND1, COX1, and COX3, whose association with colorec-
tal cancer has already been well investigated [77, 78].
Interestingly, in most females NUMTs originated from
the same mitochondrial regions while in males NUMTs
originated from different regions of mtDNA.
In the yeast S. cerevisiae, mitochondrial dysfunction
leads to increase escape of mtDNA into the nucleus
[57]. Mutations in the YME1 gene induce migration of
mtDNA to the nucleus [57]. Yme1p is a multifunctional
protein, controlling mitochondrial quality, which plays
an important role in mitochondrial biology, including as-
sembly of mitochondrial respiratory complexes, and im-
portantly in mitophagy [79, 80]. We identified that 16%
of analyzed colorectal tumors contained mutations in
the YME1L1 gene (Fig. 9a, b). Mutations in Yme1L1
were also found in a variety of other types of tumors
(Fig. 9d). We demonstrate that the human homolog of
Srinivasainagendra et al. Genome Medicine  (2017) 9:31 Page 12 of 15yeast Yme1 functions as a “NUMT suppressor”. Human
YME1L1, when expressed in a mutant Yme1 yeast strain,
reduces the migration of mtDNA to the nucleus (Fig. 9g).
These observations support YME1LI as a NUMT sup-
pressor gene in humans whose inactivation leads to
increased numtogenesis. Yme1 removes the damaged or
dysfunctional mitochondria by mitophagy and maintains a
healthy pool of mitochondria in the cell [81]. These obser-
vations implicate mitophagy in mediating accumulation
and transfer of mtDNA into the nuclear genome. These
observations lead us to suggest that the mechanism
underlying numtogenesis may involve Yme1-mediated
mitophagy. Mitophagy is a stringent mechanism that con-
trols the quality of mitochondria in cells [81]. Compro-
mised mitophagy due to loss of Yme1 [80] or an acid
endonuclease DNase IIα [82] can lead to accumulation of
incompletely digested mtDNA in the cytoplasm that
ultimately ends up in the nucleus (Fig. 10).
It is conceivable that a direct physical association or
fusion between the mitochondrial and nuclear mem-
branes and encapsulation of mitochondria in the nucleus
[83, 84] may contribute to numtogenesis. Observations
supporting encapsulation of mitochondria in the nucleus
have been reported [2–5, 7–9]. The nuclear envelope
breaks down during mitosis, leading to disruption of the
physical barrier seperating the nucleoplasm and cyto-
plasm [85]. This stage of the cell cycle can provide an
opportunity for mitochondria to enter into the nucleus.
Furthermore, cancer cells often exhibit a ruptured nuclear
envelope [86]. Decreased expression of lamins, important
constituents of the nuclear membrane, contributing toFig. 10 Mechanism underlying numtogenesis. Our observations
support the role of Yme1 in numtogenesis. The role of Yme1 in the
regulation of mitophagy is well established. Mitophagy is a stringent
mechanism that controls the quality of mitochondria in cells by
degrading dysfunctional mitochondria. Compromised mitophagy
due to altered Yme1 function leads to accumulation of undigested
mtDNA in the cytoplasm that ultimately ends up in the nucleus, a
process we have named numtogenesisnuclear rupture in cancer cells, has also been reported
[87]. Lamins in the nuclear membrane bind to chromatin
and hold chromosomes in place and thus reduce chromo-
some breakage [88]. Indeed, patients with laminopathy
resulting from reduced lamin expression contain mito-
chondria in the nucleus. It is likely that loss of lamin ex-
pression in cancer cells helps migration of mitochondria
into the nucleus, resulting in eventual integration of
mtDNA into the nuclear genome. This phenomenon
might be a survival mechanism for cancer cells [13].
It is unclear how numtogenesis alters the nuclear gen-
ome functions. Tsuji and coauthors [25] hypothesized
that the underrepresentation of d-loop NUMTs in the
germline may be due to protein binding sites located in
this region, which may interrupt mtDNA fragmentation
and immigration to the nucleus. We propose an alterna-
tive mechanism which involves structural alteration of
the chromosome. Under this model, the inserted mito-
chondrial d-loop insertion functions as a telomeric t-
loop, whereby it stabilizes a double-strand break and
truncates the chromosome arm, resulting in aneuploidy.
This mechanism involves transfer of the mtDNA dis-
placement loop (d-loop) to the nuclear genome, where it
could promote aneusomy by functioning as a telomeric
“t-loop” structure, which typically caps the linear DNA
molecule with a triple-stranded loop. The insertion of a
mitochondrial d-loop could therefore directly interfere
with the secondary structure of open chromatin and his-
tone binding sites, leading to genome instability and/or
dysregulation of gene expression. The second putative
mechanism involves a mismatch between nucleotide
composition between the mtDNA origin and nuclear
DNA insertion site, which again draws from compari-
sons with work of Tsuji and coauthors [25]. Previous
work has shown that non-homologous recombination
and transposable element insertion can lead to genome
instability by modifying local methylation patterns and
altering molecular thermodynamics, which could lead to
dysregulation of the cell cycle and aneuploidy. These
two putative mechanisms are not mutually exclusive and
we anticipate that novel mechanisms will be revealed
through further investigation.Conclusions
Our study reveals that numtogenesis plays an important
role in the development of cancer and that NUMTs may
serve as a biomarker for tumorigenesis. This study also
identifies YME1L1 as the first NUMT suppressor gene in
human and demonstrate that inactivation of YME1L1 in-
duces migration of mtDNA to the nuclear genome. Ex-
ploration of mtDNA migration into the cancer genome
should provide impetus for further studies to identify
the mechanism(s) underlying numtogenesis.
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Additional file 1: Table S1. NUMT abundance in all the colorectal
tumor samples (n = 57) used in this study. (XLSX 14 kb)
Additional file 2: Figure S1. NUMT density in tumor and normal
genomes (sorted by disease (T2) and fold change in NUMT abundance
(T7)). Each peripheral node represents a TCGA sample whose blood-derived
normal and tumor genomes were used in this study. From the outside to
the inside, tracks are ordered from 1 to 7 (T1–T7). T1: Sample gender where
red nodes represent female and blue nodes represent male. T2: Disease type
information. Rectal adenocarcinoma (READ) is rendered as green bands and
colon adenocarcinoma (COAD) as red bands. T3: Age at initial pathologic
diagnosis ranging from 30 to 90 years. White and black filled bars represent
white and black race of the individual, respectively. T4: Red columns repre-
sent NUMT proportion in tumor genomes and green columns represent
blood-derived normal NUMT proportion. T5: Vital status of the patients—red
for deceased individuals and green for alive status. T6: Stage of tumor
represented in grey scale—stage I white, stage II grey, stage III dark grey,
stage IV black. T7: Fold change in NUMT abundance. Samples with <1-
fold are rendered as colored bands: 1–4-fold, blue; 4–8-fold, green; 8–12-fold,
yellow; 12–20-fold, orange; >20-fold, red. (TIF 10991 kb)
Additional file 3: Figure S2. NUMT density in tumor and normal
genomes (sorted by disease (T2) and pathologic tumor stage (T6)). Each
peripheral node represents a TCGA sample whose blood-derived normal
and tumor genomes were used in this study. From the outside to the
inside, tracks are ordered from 1 to 7 (T1–T7). T1: Sample gender where
red nodes represent female and blue nodes represent male. T2: Disease
type information. Rectal adenocarcinoma (READ) is rendered as green
bands and colon adenocarcinoma (COAD) as red bands. T3: Age at initial
pathologic diagnosis ranging from 30 to 90 years. White and black filled
bars represent white and black race of the individual, respectively. T4: Red
columns represent NUMT proportion in tumor genomes and green columns
represent blood-derived normal NUMT proportion. T5: Vital status of the
patients—red for deceased individuals and green for alive status. T6: Stage of
tumor represented in grey scale—stage I white, stage II grey, stage III dark
grey, stage IV black. T7: Fold change in NUMT abundance. Samples with <1-
fold are rendered as colored bands: 1–4-fold, blue; 4–8-fold, green; 8–12-fold,
yellow; 12–20-fold, orange; >20-fold, red. (TIF 10662 kb)Abbreviations
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